Market Performance - The Sci-Tech Innovation Board (STAR Market) index rose by 1.17%, closing at 1032.84 points, with a total trading volume of 4.548 billion shares and a turnover of 141.659 billion yuan, resulting in a weighted average turnover rate of 2.53% [1] - Among the tradable stocks on the STAR Market, 470 stocks closed higher, with 3 stocks increasing by over 10% and 36 stocks rising between 5% and 10%. Conversely, 111 stocks closed lower [1] - The highest turnover rate was recorded by Xinyuren at 20.25%, closing up by 1.89%, with a transaction amount of 340 million yuan. Other notable stocks included Qingyun Technology, which closed down by 2.81% with a turnover rate of 18.72% [1][3] Sector Analysis - In terms of sector performance, the pharmaceutical and biotechnology sector had the highest number of stocks with a turnover rate exceeding 5%, totaling 29 stocks. The electronics and machinery equipment sectors followed with 21 and 12 stocks, respectively [2] - Among high turnover stocks, 48 experienced net inflows of main funds, with the highest net inflows recorded for Aibo Medical (99.31 million yuan), Maolai Optical (78.81 million yuan), and ST Nuotai (67.05 million yuan) [2] Leverage Fund Movements - A total of 76 stocks with high turnover rates saw net purchases from leveraged funds, with significant increases in financing balances for Shangwei New Materials (247 million yuan), Dingtong Technology (203 million yuan), and Shijia Photon (174 million yuan) [2]

民生证券股份有限公司 关于深圳市信宇人科技股份有限公司 核心技术人员调整的核查意见 截至本核查意见出具日，蔡智园先生通过深圳市智慧树投资合伙企业（有限 合伙）间接持有公司股份 145,508 股（均为首发前限售流通股），占公司总股本 比例为 0.1489%。蔡智园先生将继续遵守《上海证券交易所科创板股票上市规则》 《上市公司股东减持股份管理暂行办法》《上海证券交易所上市公司自律监管指 引第 15 号——股东及董事、高级管理人员减持股份》等相关法律法规及公司首 次公开发行股票时所作的相关承诺。 （二）参与的研发项目和专利情况 1 截至本核查意见出具日，蔡智园先生作为发明人申请的专利均系依托公司平 台所产生的职务成果，所有权均归属于公司，不存在涉及职务成果、知识产权相 关的纠纷或潜在纠纷的情形，其岗位调整不影响公司专利等知识产权权属的完整 性。 （三）保密及竞业限制情况 民生证券股份有限公司（以下简称"民生证券"或"保荐机构"）作为深圳 市信宇人科技股份有限公司（以下简称"信宇人"或"公司"）首次公开发行股 票并在科创板上市的保荐机构，根据《证券发行上市保荐业务管理办法》《上海 证券交易所科创板股票上市规则》《上 ...

证券代码：688573 证券简称：信宇人 公告编号：2025-033 深圳市信宇人科技股份有限公司 关于核心技术人员调整的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示: 深圳市信宇人科技股份有限公司（以下简称"公司"）经审慎研究，对 公司现有核心技术人员进行调整：原核心技术人员蔡智园先生因工作调整，不再 认定为公司核心技术人员，但仍继续在公司任职。经公司管理层研究，新增认定 杨星先生为公司核心技术人员，其他核心技术人员未发生变化。 本次核心技术人员调整不涉及专利权属纠纷或潜在纠纷，不会影响公司 专利权的完整，亦不会对公司持续经营能力、研发实力、核心竞争力产生重大不 利影响。 一、核心技术人员调整的具体情况 因蔡智园先生工作调整，公司不再认定其为核心技术人员，但后续仍在公司 任职。公司及公司董事会对蔡智园先生在担任公司核心技术人员期间为公司发展 所做出的贡献表示衷心感谢。 公司专案经理；2014 年 12 月至今，任职公司产品总监。 截至本公告披露日，蔡智园先生通过深圳市智慧树投资合伙企业（有限合伙） ...

Market Performance - The Sci-Tech Innovation Board (STAR Market) index rose by 0.83%, closing at 1016.27 points, with a total trading volume of 4.233 billion shares and a turnover of 141.488 billion yuan, resulting in an average turnover rate of 2.35% [1] - Among the tradable stocks on the STAR Market, 278 stocks closed higher, with 6 stocks rising over 10%, including Tiedao Construction Machinery, Fuxin Technology, and Shangwei New Materials, which hit the daily limit [1] - The distribution of turnover rates shows that 2 stocks had turnover rates exceeding 20%, 25 stocks had rates between 10% and 20%, and 75 stocks had rates between 5% and 10% [1] Stock Highlights - The stock with the highest turnover rate was Xinyuren, which closed up 6.63% with a turnover rate of 27.89% and a transaction amount of 477 million yuan [1] - Sairun Bio also performed well, closing up 9.60% with a turnover rate of 20.23% and a transaction amount of 216 million yuan [1] - Other notable stocks with high turnover rates included ST Nuotai, Yitang Co., and Zhongrun Optics, with turnover rates of 19.32%, 15.92%, and 15.17% respectively [1] Sector Analysis - In terms of sector performance, the pharmaceutical and biotechnology sector had the most stocks with a turnover rate exceeding 5%, totaling 29 stocks, followed by the electronics and computer sectors with 18 and 13 stocks respectively [2] - Among the high turnover stocks, 43 experienced net inflows of main funds, with ST Nuotai, Meidi West, and Fudan Zhangjiang seeing the largest net inflows of 258.61 million yuan, 83.74 million yuan, and 68.79 million yuan respectively [2] Leverage Fund Movements - A total of 74 stocks with high turnover rates received net purchases from leveraged funds, with Dingtong Technology, Weichip Bio, and Qianyan Bio seeing the largest increases in financing balances of 143 million yuan, 138 million yuan, and 118 million yuan respectively [2] - Conversely, stocks like Haibo Sichuang, Changyang Technology, and Jinchengzi experienced significant decreases in financing balances, with reductions of 208 million yuan, 34.31 million yuan, and 32.02 million yuan respectively [2]

Market Overview - As of July 22, the Shanghai Composite Index closed at 3581.86 points, up by 22.07 points, a rise of 0.62% [1] - The Shenzhen Component Index closed at 11099.83 points, increasing by 92.34 points, a rise of 0.84% [1] - The ChiNext Index closed at 2310.86 points, up by 13.97 points, a rise of 0.61% [1] High Turnover Stocks - A total of 105 A-shares had a turnover rate exceeding 20% on July 22 [1] - Notable stocks with high turnover rates include: - Fangzheng Valve (证券代码: 920082) with a turnover rate of 58.38% and a closing price of 27.44 yuan, up by 29.99% [1] - Beifang Changlong (证券代码: 301357) with a turnover rate of 54.29% and a closing price of 90.08 yuan, up by 8.50% [1] - Zhongshe Consulting (证券代码: 833873) with a turnover rate of 50.05% and a closing price of 11.52 yuan, up by 19.50% [1] Additional High Turnover Stocks - Other stocks with significant turnover rates include: - Tietuo Machinery (证券代码: 873706) with a turnover rate of 49.66% and a closing price of 31.21 yuan, up by 29.99% [1] - Feilu Co., Ltd. (证券代码: 300665) with a turnover rate of 49.62% and a closing price of 11.44 yuan, up by 10.21% [1] - Huadian New Energy (证券代码: 600930) with a turnover rate of 47.04% and a closing price of 7.73 yuan, up by 2.25% [1]

Core Viewpoint - The company, Xinyuren, which claims to be a leader in lithium battery intelligent equipment, is facing significant operational challenges despite its technological claims and partnerships with major players like CATL and BYD. The company's financial performance has deteriorated sharply, revealing a disconnect between its technological narrative and actual business performance [1][2]. Financial Performance - In 2024, Xinyuren reported a slight revenue increase of 4.75% to 622 million yuan, but net profit plummeted by 208.41% to a loss of 63.26 million yuan, with a non-recurring net loss of 79.27 million yuan [1][3][6]. - The gross margins for the company's main products, including lithium battery drying equipment and coating equipment, have decreased significantly, with reductions of 6.67, 7.56, and 13.47 percentage points respectively [3][5]. Business Operations - The company has three major projects funded by its IPO that have been delayed, with the intelligent equipment manufacturing project postponed from 2024 to 2026 [1][6]. - Xinyuren's reliance on a few major clients is concerning, with the largest client accounting for 61.24% of total sales and the top five clients representing 86.33% [9][10]. Market Environment - The lithium battery equipment market is experiencing structural overcapacity, leading to intensified price competition and a decline in industry profitability, with utilization rates below 50% [7][8]. - The industry is shifting from price competition to performance and technology competition, with leading companies like CATL and BYD advancing solid-state battery technologies, which may threaten Xinyuren's market position [8][9]. Future Outlook - The company faces increasing financial risks due to high accounts receivable and a significant rise in bad debt provisions, with operating cash flow negative for three consecutive years [6][9]. - The technological advancements of competitors and the potential in-house production capabilities of major clients pose additional threats to Xinyuren's business model [9][10].

Market Performance - The Sci-Tech Innovation Board (STAR Market) index rose by 0.19%, closing at 1007.53 points, with a total trading volume of 3.622 billion shares and a turnover of 124.775 billion yuan, resulting in an average turnover rate of 2.02% [1] - Among the tradable stocks on the STAR Market, 324 stocks closed higher, with 9 stocks experiencing a rise of over 10%, including Electric Wind Power, Fumiao Technology, and Shangwei New Materials, which hit the daily limit [1] - The distribution of turnover rates shows that 2 stocks had turnover rates exceeding 20%, 24 stocks had rates between 10% and 20%, and 59 stocks had rates between 5% and 10% [1] High Turnover Stocks - The stock with the highest turnover rate was Xinyuren, which closed up by 3.51% with a turnover rate of 23.24% and a transaction amount of 368 million yuan [3] - Other notable stocks included Aerospace Nanhu, which rose by 5.00% with a turnover rate of 20.06%, and Suochen Technology, which had a turnover rate of 19.66% [3] Sector Analysis - In terms of sector performance, the pharmaceutical and biotechnology sector had the most stocks with a turnover rate exceeding 5%, totaling 32 stocks, followed by the computer and electronics sectors with 18 and 7 stocks, respectively [2] - Among the high turnover stocks, 58 stocks rose today, with Fumiao Technology, Olin Biology, and DeMa Technology leading with increases of 20.02%, 18.93%, and 14.74%, respectively [2] Capital Flow - In terms of capital flow, 48 stocks with high turnover rates saw net inflows from main funds, with the highest net inflows recorded for Youkede, Kaiyin Technology, and Rongchang Biology, amounting to 104 million yuan, 9.403 million yuan, and 6.991 million yuan, respectively [2] - Conversely, the stocks with the largest net outflows included Guokexingong, Maiwei Biology, and Jiayuan Technology, with net outflows of 239 million yuan, 16.9 million yuan, and 13.4 million yuan, respectively [2] Leverage Fund Movements - A total of 51 stocks with high turnover rates recently received net purchases from leveraged funds, with notable increases in financing balances for Gaoce Shares, Shijia Photon, and Weixin Biology, which saw increases of 72.986 million yuan, 71.531 million yuan, and 71.373 million yuan, respectively [2]

Group 1 - The company held its 21st meeting of the 3rd Supervisory Board on July 4, 2025, in Huizhou, with all procedures complying with relevant laws and regulations [1] - The Supervisory Board unanimously approved the correction of accounting errors and the revision of periodic reports, ensuring that the financial data accurately reflects the company's financial status and operational results [1] - The meeting was attended by three supervisors, and the voting results showed 3 votes in favor, with no opposition or abstentions [2] Group 2 - The Supervisory Board agreed that using self-owned funds to pay for fundraising project expenses and replacing them with equivalent raised funds would enhance the efficiency of fund usage [2] - The implementation of this matter will not affect the normal progress of fundraising projects and does not violate any regulations regarding the use of raised funds [2] - The voting results for this proposal also showed 3 votes in favor, with no opposition or abstentions [2]

Core Viewpoint - The company, Shenzhen Xinyuren Technology Co., Ltd., is utilizing its own funds to pay for fundraising project expenses and will subsequently replace these with equivalent amounts from the raised funds, ensuring compliance with regulatory requirements and maintaining project efficiency [1][2][4]. Fundraising Overview - The company has successfully completed its initial public offering (IPO) of 24,438,597 shares at a price of RMB 23.68 per share, raising a total of approximately RMB 578.71 million. After deducting issuance costs of about RMB 72.51 million, the net proceeds amount to approximately RMB 506.20 million [1][2]. - The total investment for the fundraising projects is RMB 618.52 million, with RMB 462.25 million allocated from the raised funds [1]. Fund Utilization and Replacement Process - The company has opted to use its own funds for certain project expenses, particularly for land purchases, due to tax payment requirements that necessitate using a specific account not linked to the fundraising account. This approach allows for timely payments while ensuring that the raised funds are eventually used to reimburse these expenses [1][2]. - The process involves the company’s relevant departments preparing detailed payment records, followed by internal approvals, and then transferring equivalent amounts from the fundraising account to the company’s general account [2][4]. Impact on Company Operations - The decision to use self-funds for project expenses and later replace them with raised funds is expected to enhance the efficiency of fund utilization and project implementation, ensuring that the projects proceed smoothly without altering the intended use of the raised funds [4][5]. Approval and Oversight - The board of directors approved the use of self-funds for project expenses with a unanimous vote, and the supervisory board expressed agreement, confirming that this action does not affect the normal operation of the fundraising projects or violate any regulatory requirements [5][6]. - The sponsoring institution, Minsheng Securities, has conducted a review and found that the company has adhered to necessary procedures and regulations regarding the use of funds [6].

Overview - The company, Shenzhen Xinyuren Technology Co., Ltd., has announced corrections to its financial reports due to accounting errors related to revenue recognition and cash flow statements [1][4]. Accounting Errors and Corrections - The company identified an accounting error in revenue recognition for a transaction involving its subsidiary, Dongguan Jianxin Tianlan Technology Co., Ltd. The revenue was initially recognized using the gross method but was corrected to the net method, resulting in a revenue adjustment from RMB 68,141,592.93 to RMB 16,814,159.33 [2][3]. - The company also failed to offset internal cash flows of RMB 51,000,000.00 between the parent and subsidiary when preparing the consolidated cash flow statement for Q3 2024, leading to inaccuracies in cash flow reporting [3][4]. Financial Impact of Corrections - The adjustments affected various financial metrics, including accounts receivable, inventory, total assets, and net profit. For instance, the accounts receivable was adjusted from RMB 496,581,366.69 to RMB 435,617,966.69 [4][5]. - The net profit for the first half of 2024 was revised from RMB -32,868,195.23 to RMB -43,409,402.98, reflecting a significant impact on the company's financial performance [5][6]. Board and Committee Opinions - The Audit Committee and Board of Directors have reviewed and approved the corrections, confirming that the adjustments comply with relevant accounting standards and regulations [8][9]. - The company has committed to enhancing its internal control systems and financial management practices to prevent similar issues in the future [8][9].